CN104926798B - 阿法替尼中间体的高纯度制备方法 - Google Patents
阿法替尼中间体的高纯度制备方法 Download PDFInfo
- Publication number
- CN104926798B CN104926798B CN201410106940.9A CN201410106940A CN104926798B CN 104926798 B CN104926798 B CN 104926798B CN 201410106940 A CN201410106940 A CN 201410106940A CN 104926798 B CN104926798 B CN 104926798B
- Authority
- CN
- China
- Prior art keywords
- compound
- formula
- reaction
- added
- purity
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Description
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410106940.9A CN104926798B (zh) | 2014-03-21 | 2014-03-21 | 阿法替尼中间体的高纯度制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410106940.9A CN104926798B (zh) | 2014-03-21 | 2014-03-21 | 阿法替尼中间体的高纯度制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104926798A CN104926798A (zh) | 2015-09-23 |
CN104926798B true CN104926798B (zh) | 2019-06-18 |
Family
ID=54114251
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410106940.9A Active CN104926798B (zh) | 2014-03-21 | 2014-03-21 | 阿法替尼中间体的高纯度制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104926798B (zh) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105175400B (zh) * | 2015-09-29 | 2018-04-10 | 河北神威药业有限公司 | 一种阿法替尼中间体的制备方法 |
CN105712940A (zh) * | 2016-02-26 | 2016-06-29 | 南京师范大学 | 一种阿法替尼中间体6-硝基-7-氯-4-喹唑啉酮的制备方法 |
CN107216317B (zh) * | 2016-03-21 | 2020-04-07 | 上海医药工业研究院 | 一种阿法替尼中间体的制备方法 |
CN107488171B (zh) * | 2016-06-10 | 2020-08-28 | 山东新时代药业有限公司 | 一种阿法替尼制备方法 |
CN107488153B (zh) * | 2016-06-10 | 2020-06-23 | 山东新时代药业有限公司 | 一种阿法替尼中间体化合物 |
CN111518088B (zh) * | 2020-06-10 | 2021-09-03 | 山东创新药物研发有限公司 | 一种苯胺喹唑啉类中间体的制备方法及应用 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1539805A (zh) * | 2003-10-24 | 2004-10-27 | 中国科学院广州化学研究所 | 紫檀芪的合成方法 |
CN102686581A (zh) * | 2009-12-21 | 2012-09-19 | 张强 | 新的喹唑啉衍生物 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1720841B1 (en) * | 2004-02-19 | 2015-11-04 | Rexahn Pharmaceuticals, Inc. | Quinazoline derivatives and therapeutic use thereof |
CN101723906B (zh) * | 2008-10-10 | 2011-09-28 | 山西仁源堂药业有限公司 | 一种化合物、含该化合物的药物组合物及制备方法和用途 |
-
2014
- 2014-03-21 CN CN201410106940.9A patent/CN104926798B/zh active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1539805A (zh) * | 2003-10-24 | 2004-10-27 | 中国科学院广州化学研究所 | 紫檀芪的合成方法 |
CN102686581A (zh) * | 2009-12-21 | 2012-09-19 | 张强 | 新的喹唑啉衍生物 |
Also Published As
Publication number | Publication date |
---|---|
CN104926798A (zh) | 2015-09-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104926798B (zh) | 阿法替尼中间体的高纯度制备方法 | |
CN108558800A (zh) | 一种低成本的2,5-呋喃二甲酸的工业化制备方法 | |
CN105418603A (zh) | 一种高纯度帕布昔利布及其反应中间体的制备方法 | |
Guo et al. | Cu (i)-catalyzed chemical fixation of CO 2 with 2-alkynylaniline into 4-hydroxyquinolin-2 (1 H)-one | |
CN114315595B (zh) | 一种碳负载铁基催化剂的制备方法及其抗癌抑制剂中间体合成应用 | |
CN102367260A (zh) | 2-氨基嘧啶-5-硼酸的合成方法 | |
CN102911164A (zh) | 一种拉帕替尼关键中间体的制备方法 | |
CN105153149A (zh) | 一种选择性激酶抑制剂Palbociclib的制备方法 | |
CN106674084B (zh) | 一种2-异丙基氧基-5-甲基-4-(哌啶-4-基)苯胺二盐酸盐的制备方法 | |
CN104072492A (zh) | 一种抗肿瘤靶向治疗药物Tivozanib的合成方法 | |
CN106810554B (zh) | 一种他达拉非化合物的制备方法 | |
CN105732490A (zh) | 一种贝曲西班的制备方法 | |
CN102718662A (zh) | 一种制备盐酸西那卡塞的方法 | |
CN101519407B (zh) | 一种可具有取代基的环酸酐的合成方法 | |
CN103787968B (zh) | 化合物的制备方法 | |
CN104130181B (zh) | 一种2,2,6,6-四甲基-4-哌啶酮的连续合成方法 | |
CN106854200B (zh) | 色瑞替尼及其中间体的制备方法 | |
CN106146327B (zh) | 一种d-环丝氨酸中间体的合成方法 | |
CN105418613B (zh) | 一种腺嘌呤的绿色环保制备方法 | |
CN106187887B (zh) | 4-羟基喹啉-3-甲酸的制备方法 | |
CN109988108A (zh) | 一种卡博替尼的制备方法 | |
CN107674022A (zh) | 一种帕博西林中间体的合成方法 | |
CN109879800B (zh) | 一种贝他斯汀药物中间体的制备工艺 | |
CN106008363B (zh) | 2-甲基-4-氨基-5-氰基嘧啶的制备方法 | |
CN106632260B (zh) | 一种小分子激酶抑制剂的制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
CB02 | Change of applicant information |
Address after: Tenth Industrial Zone, Lianyungang, Jiangsu, China, 222047 Applicant after: JIANGSU HANSOH PHARMACEUTICAL Co.,Ltd. Applicant after: Lianyungang Hongchuang Pharmaceutical Co.,Ltd. Address before: Tenth Industrial Zone, Lianyungang, Jiangsu, China, 222047 Applicant before: JIANGSU HANSOH PHARMACEUTICAL Co.,Ltd. Applicant before: JIANGSU HANSOH PHARMACEUTICAL GROUP LIANYUNGANG HONGCHUANG PHARMACEUTICAL Co.,Ltd. |
|
COR | Change of bibliographic data | ||
C41 | Transfer of patent application or patent right or utility model | ||
CB02 | Change of applicant information |
Address after: Tenth Industrial Zone, Lianyungang, Jiangsu, China, 222047 Applicant after: JIANGSU HANSOH PHARMACEUTICAL GROUP Co.,Ltd. Applicant after: Lianyungang Hongchuang Pharmaceutical Co.,Ltd. Address before: Tenth Industrial Zone, Lianyungang, Jiangsu, China, 222047 Applicant before: Jiangsu best Pharmaceutical Co.,Ltd. Applicant before: Lianyungang Hongchuang Pharmaceutical Co.,Ltd. Address after: Tenth Industrial Zone, Lianyungang, Jiangsu, China, 222047 Applicant after: Jiangsu best Pharmaceutical Co.,Ltd. Applicant after: Lianyungang Hongchuang Pharmaceutical Co.,Ltd. Address before: Tenth Industrial Zone, Lianyungang, Jiangsu, China, 222047 Applicant before: JIANGSU HANSOH PHARMACEUTICAL Co.,Ltd. Applicant before: Lianyungang Hongchuang Pharmaceutical Co.,Ltd. |
|
COR | Change of bibliographic data | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20160315 Address after: Tenth Industrial Zone, Lianyungang, Jiangsu, China, 222047 Applicant after: JIANGSU HANSOH PHARMACEUTICAL GROUP Co.,Ltd. Address before: Tenth Industrial Zone, Lianyungang, Jiangsu, China, 222047 Applicant before: JIANGSU HANSOH PHARMACEUTICAL GROUP Co.,Ltd. Applicant before: Lianyungang Hongchuang Pharmaceutical Co.,Ltd. |
|
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |